PFG Advisors Lowers Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

PFG Advisors cut its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 3.2% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 4,401 shares of the financial services provider’s stock after selling 145 shares during the quarter. PFG Advisors’ holdings in iShares Biotechnology ETF were worth $582,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. BNP Paribas Financial Markets increased its stake in shares of iShares Biotechnology ETF by 29.3% in the third quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock worth $346,561,000 after buying an additional 538,899 shares during the period. Raymond James Financial Inc. bought a new stake in iShares Biotechnology ETF in the fourth quarter valued at $55,010,000. Healthcare of Ontario Pension Plan Trust Fund boosted its holdings in shares of iShares Biotechnology ETF by 32.9% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock valued at $96,533,000 after buying an additional 164,000 shares in the last quarter. Aprio Wealth Management LLC bought a new stake in shares of iShares Biotechnology ETF during the 4th quarter valued at $18,476,000. Finally, Generali Investments CEE investicni spolecnost a.s. bought a new stake in shares of iShares Biotechnology ETF during the 4th quarter valued at $11,370,000. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Trading Up 0.8 %

Shares of IBB stock opened at $134.19 on Friday. The stock has a market cap of $6.34 billion, a PE ratio of 24.52 and a beta of 0.84. The company’s fifty day moving average price is $136.25 and its 200-day moving average price is $139.96. iShares Biotechnology ETF has a 12 month low of $123.60 and a 12 month high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were paid a $0.0624 dividend. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.